These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11575733)

  • 1. Augmentation and combination strategies in treatment-resistant depression.
    Fava M
    J Clin Psychiatry; 2001; 62 Suppl 18():4-11. PubMed ID: 11575733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 6():16-25. PubMed ID: 19922740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of nonresponse and intolerance: switching strategies.
    Fava M
    J Clin Psychiatry; 2000; 61 Suppl 2():10-2. PubMed ID: 10714618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching antidepressants for treatment-resistant major depression.
    Marangell LB
    J Clin Psychiatry; 2001; 62 Suppl 18():12-7. PubMed ID: 11575730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining antidepressants for treatment-resistant depression: a review.
    Lam RW; Wan DD; Cohen NL; Kennedy SH
    J Clin Psychiatry; 2002 Aug; 63(8):685-93. PubMed ID: 12197448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies in treatment-resistant depression.
    Alao AO; Malhotra K; Pies R; Dewan MJ
    West Afr J Med; 2003 Sep; 22(3):211-8. PubMed ID: 14696943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of antidepressant nonresponders: augmentation or switch?
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 15():35-41. PubMed ID: 9786309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation strategies for treatment-resistant depression: a literature review.
    Carvalho AF; Cavalcante JL; Castelo MS; Lima MC
    J Clin Pharm Ther; 2007 Oct; 32(5):415-28. PubMed ID: 17875106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation strategies in depression 2000.
    Nelson JC
    J Clin Psychiatry; 2000; 61 Suppl 2():13-9. PubMed ID: 10714619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation strategies for treatment-resistant depression.
    Carvalho AF; Machado JR; Cavalcante JL
    Curr Opin Psychiatry; 2009 Jan; 22(1):7-12. PubMed ID: 19122528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation and combination strategies for complicated depression.
    Fava M
    J Clin Psychiatry; 2009 Nov; 70(11):e40. PubMed ID: 20031088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What role do atypical antipsychotic drugs have in treatment-resistant depression?
    Thase ME
    J Clin Psychiatry; 2002 Feb; 63(2):95-103. PubMed ID: 11874227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
    Hirschfeld RM; Montgomery SA; Aguglia E; Amore M; Delgado PL; Gastpar M; Hawley C; Kasper S; Linden M; Massana J; Mendlewicz J; Möller HJ; Nemeroff CB; Saiz J; Such P; Torta R; Versiani M
    J Clin Psychiatry; 2002 Sep; 63(9):826-37. PubMed ID: 12363125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing treatment-resistant major depression.
    Nelson JC
    J Clin Psychiatry; 2003; 64 Suppl 1():5-12. PubMed ID: 12625799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium augmentation of antidepressants in treatment-refractory depression.
    Heit S; Nemeroff CB
    J Clin Psychiatry; 1998; 59 Suppl 6():28-33; discussion 34. PubMed ID: 9674934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antidepressants in novel combination therapies.
    Shelton RC
    J Clin Psychiatry; 2003; 64 Suppl 2():14-8. PubMed ID: 12625794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for clinically relevant research on treatment-resistant depression.
    Thase ME
    J Clin Psychiatry; 2001 Apr; 62(4):221-4. PubMed ID: 11379833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.